Abbott Laboratories Stock Analysis
ABT Stock | USD 130.61 1.18 0.90% |
Abbott Laboratories is undervalued with Real Value of 139.71 and Target Price of 130.62. The main objective of Abbott Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what Abbott Laboratories is worth, separate from its market price. There are two main types of Abbott Laboratories' stock analysis: fundamental analysis and technical analysis.
The Abbott Laboratories stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Abbott Laboratories is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Abbott Stock trading window is adjusted to America/New York timezone.
Abbott |
Abbott Stock Analysis Notes
About 79.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.35. Abbott Laboratories recorded earning per share (EPS) of 7.64. The entity last dividend was issued on the 15th of January 2025. The firm had 10000:4798 split on the 2nd of January 2013. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people. For more info on Abbott Laboratories please contact Miles White at 224 667 6100 or go to https://www.abbott.com.Abbott Laboratories Quarterly Total Revenue |
|
Abbott Laboratories Investment Alerts
Over 79.0% of the company shares are held by institutions such as insurance companies | |
On 14th of February 2025 Abbott Laboratories paid $ 0.59 per share dividend to its current shareholders | |
Latest headline from washingtonexaminer.com: Dallas police refuse to cooperate with ICE, defy Abbott on Trump deportation effort |
Abbott Laboratories Upcoming and Recent Events
17th of April 2024 Upcoming Quarterly Report | View | |
18th of July 2024 Next Financial Report | View | |
31st of March 2024 Next Fiscal Quarter End | View | |
22nd of January 2025 Next Fiscal Year End | View | |
31st of December 2023 Last Quarter Report | View | |
31st of December 2023 Last Financial Announcement | View |
Abbott Largest EPS Surprises
Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2017-04-19 | 2017-03-31 | 0.43 | 0.48 | 0.05 | 11 | ||
2015-04-22 | 2015-03-31 | 0.42 | 0.47 | 0.05 | 11 | ||
2014-04-16 | 2014-03-31 | 0.36 | 0.41 | 0.05 | 13 |
Abbott Laboratories Environmental, Social, and Governance (ESG) Scores
Abbott Laboratories' ESG score is a quantitative measure that evaluates Abbott Laboratories' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Abbott Laboratories' operations that may have significant financial implications and affect Abbott Laboratories' stock price as well as guide investors towards more socially responsible investments.
Abbott Laboratories Thematic Classifications
In addition to having Abbott Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Obamacare RepealLarge healthcare related equities associated with Obamacare | |
![]() | SRI Sustainable GrowthLarge and mid-sized companies that operate under the guidelines of socially responsible investing - SRI | |
![]() | CompulsionAddiction driven consumer products and services |
Abbott Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Legal & General Group Plc | 2024-09-30 | 14.3 M | Polen Capital | 2024-09-30 | 13.9 M | Bank Of New York Mellon Corp | 2024-12-31 | 13.6 M | State Farm Mutual Automobile Ins Co | 2024-09-30 | 13.6 M | Massachusetts Financial Services Company | 2024-09-30 | 13.3 M | Charles Schwab Investment Management Inc | 2024-12-31 | 12.9 M | Ameriprise Financial Inc | 2024-09-30 | 12.1 M | Deutsche Bank Ag | 2024-09-30 | 11.5 M | Bank Of America Corp | 2024-09-30 | 11.4 M | Vanguard Group Inc | 2024-09-30 | 167.9 M | Blackrock Inc | 2024-09-30 | 131 M |
Abbott Market Capitalization
The company currently falls under 'Mega-Cap' category with a total capitalization of 226.54 B.Abbott Profitablity
The company has Net Profit Margin of 0.32 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.16 | 0.17 | |
Return On Capital Employed | 0.13 | 0.24 | |
Return On Assets | 0.09 | 0.12 | |
Return On Equity | 0.17 | 0.26 |
Management Efficiency
Abbott Laboratories has Return on Asset of 0.0649 % which means that on every $100 spent on assets, it made $0.0649 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3399 %, implying that it generated $0.3399 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.17 in 2025. Return On Capital Employed is likely to gain to 0.24 in 2025. At this time, Abbott Laboratories' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 24.8 B in 2025, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 20.15 | 21.16 | |
Tangible Book Value Per Share | 4.20 | 4.41 | |
Enterprise Value Over EBITDA | 16.96 | 17.81 | |
Price Book Value Ratio | 4.45 | 2.62 | |
Enterprise Value Multiple | 16.96 | 17.81 | |
Price Fair Value | 4.45 | 2.62 | |
Enterprise Value | 179.9 B | 188.9 B |
Abbott Laboratories' management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Technical Drivers
As of the 16th of February 2025, Abbott Laboratories shows the risk adjusted performance of 0.1114, and Mean Deviation of 0.8828. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Abbott Laboratories Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Abbott Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Abbott Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Abbott Laboratories Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abbott Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abbott Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abbott Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Daniel Salvadori over two weeks ago Disposition of 23771 shares by Daniel Salvadori of Abbott Laboratories at 38.4 subject to Rule 16b-3 | ||
Hubert Allen over two weeks ago Disposition of 131360 shares by Hubert Allen of Abbott Laboratories at 38.4 subject to Rule 16b-3 | ||
Louis Morrone over two weeks ago Disposition of 2644 shares by Louis Morrone of Abbott Laboratories at 127. subject to Rule 16b-3 | ||
Mccoy John A. Jr. over three months ago Disposition of tradable shares by Mccoy John A. Jr. of Abbott Laboratories at 113.27 subject to Rule 16b-3 | ||
Robert Alpern over six months ago Acquisition by Robert Alpern of tradable shares of Abbott Laboratories subject to Rule 16b-3 |
Abbott Laboratories Outstanding Bonds
Abbott Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbott Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbott bonds can be classified according to their maturity, which is the date when Abbott Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ABBOTT LABS 295 Corp BondUS002824BB55 | View | |
ABBOTT LABS 6 Corp BondUS002824AV29 | View | |
ABBOTT LABS 53 Corp BondUS002824AY67 | View | |
US002824BP42 Corp BondUS002824BP42 | View | |
US002824BQ25 Corp BondUS002824BQ25 | View | |
ABBOTT LABS 475 Corp BondUS002824BG43 | View | |
US002824BF69 Corp BondUS002824BF69 | View | |
ABBOTT LABS 49 Corp BondUS002824BH26 | View |
Abbott Laboratories Predictive Daily Indicators
Abbott Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abbott Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 0.0161 | |||
Daily Balance Of Power | (0.55) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 131.59 | |||
Day Typical Price | 131.26 | |||
Market Facilitation Index | 2.13 | |||
Price Action Indicator | (1.56) | |||
Period Momentum Indicator | (1.18) | |||
Relative Strength Index | 68.01 |
Abbott Laboratories Corporate Filings
F4 | 7th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 31st of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 30th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 23rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Abbott Laboratories Forecast Models
Abbott Laboratories' time-series forecasting models are one of many Abbott Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abbott Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Abbott Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Abbott Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abbott shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Abbott Laboratories. By using and applying Abbott Stock analysis, traders can create a robust methodology for identifying Abbott entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.19 | 0.21 | |
Operating Profit Margin | 0.19 | 0.21 | |
Net Profit Margin | 0.16 | 0.15 | |
Gross Profit Margin | 0.63 | 0.62 |
Current Abbott Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abbott analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Abbott analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
130.62 | Strong Buy | 27 | Odds |
Most Abbott analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abbott stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abbott Laboratories, talking to its executives and customers, or listening to Abbott conference calls.
Abbott Stock Analysis Indicators
Abbott Laboratories stock analysis indicators help investors evaluate how Abbott Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Abbott Laboratories shares will generate the highest return on investment. By understating and applying Abbott Laboratories stock analysis, traders can identify Abbott Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow | 9.9 B | |
Long Term Debt | 13.6 B | |
Common Stock Shares Outstanding | 1.7 B | |
Total Stockholder Equity | 38.6 B | |
Tax Provision | 1 B | |
Quarterly Earnings Growth Y O Y | 4.801 | |
Property Plant And Equipment Net | 11.3 B | |
Cash And Short Term Investments | 7.3 B | |
Cash | 6.9 B | |
Accounts Payable | 4.3 B | |
Net Debt | 9 B | |
50 Day M A | 119.1342 | |
Total Current Liabilities | 13.8 B | |
Other Operating Expenses | 33.6 B | |
Non Current Assets Total | 50.5 B | |
Forward Price Earnings | 25.3807 | |
Non Currrent Assets Other | 6 B | |
Stock Based Compensation | 644 M |
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.